Becton, Dickinson and Company (BDX) Stock Forecast & Price Target

$237.35

+4.57 (+1.96%)

(As of 07/26/2024 ET)

Becton, Dickinson and Company - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 8 Analyst Ratings

Based on 8 Wall Street analysts who have issued ratings for Becton, Dickinson and Company in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 1 has given a hold rating, and 7 have given a buy rating for BDX.

Consensus Price Target

$280.13
18.02% Upside

High Forecast	$312.00
Average Forecast	$280.13
Low Forecast	$255.00

According to the 8 analysts' twelve-month price targets for Becton, Dickinson and Company, the average price target is $280.13. The highest price target for BDX is $312.00, while the lowest price target for BDX is $255.00. The average price target represents a forecasted upside of 18.02% from the current price of $237.35.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	5 Buy rating(s)	4 Buy rating(s)	7 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$280.13	$280.17	$280.00	$281.22
Forecasted Upside	18.02% Upside	16.61% Upside	15.02% Upside	11.36% Upside

Get Becton, Dickinson and Company Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

Ad Weiss Ratings

The next companies to potentially benefit thanks to Nvidia are …

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

BDX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Becton, Dickinson and Company Stock vs. The Competition

Type	Becton, Dickinson and Company	Medical Companies	S&P 500
Consensus Rating Score	2.88	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	18.02% Upside	3,123.46% Upside	9.18% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/26/2024	Stifel Nicolaus 4 of 5 stars		Boost Target	Buy ➝ Buy	$270.00 ➝ $280.00	+17.80%
7/10/2024	Citigroup 3 of 5 stars		Lower Target	Neutral ➝ Neutral	$260.00 ➝ $255.00	+13.91%
7/2/2024	Evercore ISI 2 of 5 stars		Lower Target	Outperform ➝ Outperform	$290.00 ➝ $285.00	+24.50%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$274.00	+21.82%
5/6/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$305.00 ➝ $312.00	+31.85%
1/3/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$269.00 ➝ $275.00	+13.95%
Get the Latest News and Ratings for BDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Becton, Dickinson and Company and its competitors with MarketBeat's FREE daily newsletter.
12/4/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$310.00 ➝ $280.00	+17.52%
11/10/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$305.00 ➝ $280.00	+19.33%
1/3/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$250.00 ➝ $290.00	+14.04%
11/16/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$255.00	+14.89%
11/11/2022	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Brackmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:25 AM ET.

BDX Forecast - Frequently Asked Questions

What is Becton, Dickinson and Company's forecast for 2024?: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Becton, Dickinson and Company is $280.13, with a high forecast of $312.00 and a low forecast of $255.00.
Should I buy or sell Becton, Dickinson and Company stock right now?: 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and Company in the last twelve months. There is currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" BDX shares.
Does Becton, Dickinson and Company's stock price have much upside?: According to analysts, Becton, Dickinson and Company's stock has a predicted upside of 20.08% based on their 12-month stock forecasts.
What analysts cover Becton, Dickinson and Company?: Becton, Dickinson and Company has been rated by research analysts at Barclays, Citigroup, Evercore ISI, Stifel Nicolaus, and The Goldman Sachs Group in the past 90 days.
Do Wall Street analysts like Becton, Dickinson and Company more than its competitors?: Analysts like Becton, Dickinson and Company more than other "medical" companies. The consensus rating score for Becton, Dickinson and Company is 2.88 while the average consensus rating score for "medical" companies is 2.72. Learn more on how BDX compares to other companies.